Competitive antagonism of AMPA receptors by ligands of different classes: Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX

Anders Hogner, Jeremy R. Greenwood, Tommy Liljefors, Marie Louise Lunn, Jan Egebjerg, Ingrid K. Larsen, Eric Gouaux, Jette S. Kastrup

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system. This study presents a high-resolution X-ray structure of the competitive antagonist (S)-2-amino-3-[5-tertbutyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO) in complex with the ligand-binding core of the receptor. Comparison with the only previous structure of the ligand-binding core in complex with an antagonist, 6,7-dinitro-2,3-quinoxalinedione (DNQX) (Armstrong, N.; Gouaux, E. Neuron 2000, 28, 165-181), reveals that ATPO and DNQX stabilize an open form of the ligand-binding core by different sets of interactions. Computational techniques are used to quantify the differences between these two ligands and to map the binding site. The isoxazole moiety of ATPO acts primarily as a spacer, and other scaffolds could potentially be used. Whereas agonists induce substantial domain closures compared to the apo structure, ATPO only induces minor conformational changes. These results are consistent with the hypothesis that domain closure is related to receptor activation. To facilitate the design of novel AMPA receptor antagonists, we present a modified model of the binding site that includes key residues involved in ligand recognition.

Original languageEnglish (US)
Pages (from-to)214-221
Number of pages8
JournalJournal of Medicinal Chemistry
Volume46
Issue number2
DOIs
StatePublished - Jan 16 2003
Externally publishedYes

Fingerprint

AMPA Receptors
Crystal structure
Ligands
Binding Sites
Ligand-Gated Ion Channels
Isoxazoles
Ionotropic Glutamate Receptors
Neurology
Scaffolds
Synaptic Transmission
Neurons
Central Nervous System
Chemical activation
X-Rays
X rays

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Competitive antagonism of AMPA receptors by ligands of different classes : Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX. / Hogner, Anders; Greenwood, Jeremy R.; Liljefors, Tommy; Lunn, Marie Louise; Egebjerg, Jan; Larsen, Ingrid K.; Gouaux, Eric; Kastrup, Jette S.

In: Journal of Medicinal Chemistry, Vol. 46, No. 2, 16.01.2003, p. 214-221.

Research output: Contribution to journalArticle

Hogner, Anders ; Greenwood, Jeremy R. ; Liljefors, Tommy ; Lunn, Marie Louise ; Egebjerg, Jan ; Larsen, Ingrid K. ; Gouaux, Eric ; Kastrup, Jette S. / Competitive antagonism of AMPA receptors by ligands of different classes : Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX. In: Journal of Medicinal Chemistry. 2003 ; Vol. 46, No. 2. pp. 214-221.
@article{7c2c7b3cf0054b25a5d7a29d491c46a4,
title = "Competitive antagonism of AMPA receptors by ligands of different classes: Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX",
abstract = "Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system. This study presents a high-resolution X-ray structure of the competitive antagonist (S)-2-amino-3-[5-tertbutyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO) in complex with the ligand-binding core of the receptor. Comparison with the only previous structure of the ligand-binding core in complex with an antagonist, 6,7-dinitro-2,3-quinoxalinedione (DNQX) (Armstrong, N.; Gouaux, E. Neuron 2000, 28, 165-181), reveals that ATPO and DNQX stabilize an open form of the ligand-binding core by different sets of interactions. Computational techniques are used to quantify the differences between these two ligands and to map the binding site. The isoxazole moiety of ATPO acts primarily as a spacer, and other scaffolds could potentially be used. Whereas agonists induce substantial domain closures compared to the apo structure, ATPO only induces minor conformational changes. These results are consistent with the hypothesis that domain closure is related to receptor activation. To facilitate the design of novel AMPA receptor antagonists, we present a modified model of the binding site that includes key residues involved in ligand recognition.",
author = "Anders Hogner and Greenwood, {Jeremy R.} and Tommy Liljefors and Lunn, {Marie Louise} and Jan Egebjerg and Larsen, {Ingrid K.} and Eric Gouaux and Kastrup, {Jette S.}",
year = "2003",
month = "1",
day = "16",
doi = "10.1021/jm020989v",
language = "English (US)",
volume = "46",
pages = "214--221",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Competitive antagonism of AMPA receptors by ligands of different classes

T2 - Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX

AU - Hogner, Anders

AU - Greenwood, Jeremy R.

AU - Liljefors, Tommy

AU - Lunn, Marie Louise

AU - Egebjerg, Jan

AU - Larsen, Ingrid K.

AU - Gouaux, Eric

AU - Kastrup, Jette S.

PY - 2003/1/16

Y1 - 2003/1/16

N2 - Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system. This study presents a high-resolution X-ray structure of the competitive antagonist (S)-2-amino-3-[5-tertbutyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO) in complex with the ligand-binding core of the receptor. Comparison with the only previous structure of the ligand-binding core in complex with an antagonist, 6,7-dinitro-2,3-quinoxalinedione (DNQX) (Armstrong, N.; Gouaux, E. Neuron 2000, 28, 165-181), reveals that ATPO and DNQX stabilize an open form of the ligand-binding core by different sets of interactions. Computational techniques are used to quantify the differences between these two ligands and to map the binding site. The isoxazole moiety of ATPO acts primarily as a spacer, and other scaffolds could potentially be used. Whereas agonists induce substantial domain closures compared to the apo structure, ATPO only induces minor conformational changes. These results are consistent with the hypothesis that domain closure is related to receptor activation. To facilitate the design of novel AMPA receptor antagonists, we present a modified model of the binding site that includes key residues involved in ligand recognition.

AB - Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system. This study presents a high-resolution X-ray structure of the competitive antagonist (S)-2-amino-3-[5-tertbutyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO) in complex with the ligand-binding core of the receptor. Comparison with the only previous structure of the ligand-binding core in complex with an antagonist, 6,7-dinitro-2,3-quinoxalinedione (DNQX) (Armstrong, N.; Gouaux, E. Neuron 2000, 28, 165-181), reveals that ATPO and DNQX stabilize an open form of the ligand-binding core by different sets of interactions. Computational techniques are used to quantify the differences between these two ligands and to map the binding site. The isoxazole moiety of ATPO acts primarily as a spacer, and other scaffolds could potentially be used. Whereas agonists induce substantial domain closures compared to the apo structure, ATPO only induces minor conformational changes. These results are consistent with the hypothesis that domain closure is related to receptor activation. To facilitate the design of novel AMPA receptor antagonists, we present a modified model of the binding site that includes key residues involved in ligand recognition.

UR - http://www.scopus.com/inward/record.url?scp=0037448433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037448433&partnerID=8YFLogxK

U2 - 10.1021/jm020989v

DO - 10.1021/jm020989v

M3 - Article

C2 - 12519060

AN - SCOPUS:0037448433

VL - 46

SP - 214

EP - 221

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 2

ER -